{"name":"Seaport Therapeutics","slug":"seaport-therapeutics","ticker":"","exchange":"","domain":"seaport.com","description":"Seaport Therapeutics is a biotechnology company focused on developing innovative treatments for patients with serious diseases. The company's lead candidate, SPT-300, is currently in Phase 2 clinical trials.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE53VHJBYUpXTzFPQ0tNQUp0d0ZqZVFudEhYaEc0VXgxS01XcFNPdkdCQTg1ZmpuZFZ4U29QdGNlMDEyUEhvY0R0OTgwRWRCc3EzOFdF?oc=5","date":"2026-03-04","type":"pipeline","source":"FirstWord Pharma","summary":"US agency doles out grants to tackle lymphatic dysfunction - FirstWord Pharma","headline":"US agency doles out grants to tackle lymphatic dysfunction","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_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?oc=5","date":"2026-03-03","type":"pipeline","source":"Business Wire","summary":"Seaport Therapeutics and Monash Institute of Pharmaceutical Sciences Awarded up to $15 Million from ARPA‑H to Advance Seaport’s GlyphCele™, the First Oral Therapeutic Designed to Restore Gut Lymphatic","headline":"Seaport Therapeutics and Monash Institute of Pharmaceutical Sciences Awarded up to $15 Million from ARPA‑H to Advance Se","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxPZWZmdEYtVlVNbTdNM0dFcVhYWU1SUFdRak0xd3JfZlF6Vk1Td2lod2ZmOTVxYkdZNkFTUDE1RDRzbHNCcmJFTjAtNC1CVnJlWjV4enp6V2p6dGNTQmg4ajRBZUpWVXQweHhhV0dfVjJlWG1HZEFMY0hIQ2pFdzBocUE4d1JfOGZjaGpMbW1QVWRxdw?oc=5","date":"2025-09-22","type":"pipeline","source":"Fierce Biotech","summary":"Introducing Fierce Biotech's 2025 Fierce 15 - Fierce Biotech","headline":"Introducing Fierce Biotech's 2025 Fierce 15","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMieEFVX3lxTE5fc2d2REFSaVJFYktybzlTbFRpN2VidkdiU1N3Y0RvajNXUmFMWVRBa1g5cWFQdndTY2IyRmNTeHEyQkEwdnNtOVhEeEk0RWI2aDU2NkotNjRnYjYzTTIwVzVtakxyMmgzM2RreWY1QzdNNUlhcW5raw?oc=5","date":"2025-08-07","type":"earnings","source":"Yahoo Finance","summary":"The RMR Group Announces $1.0 Billion Refinancing of Vertex Pharmaceuticals’ Headquarters in Boston Seaport District - Yahoo Finance","headline":"The RMR Group Announces $1.0 Billion Refinancing of Vertex Pharmaceuticals’ Headquarters in Boston Seaport District","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxNa3FqSjhoZTByUElrS1R2cmF0a3pNa056NVlGRVBUMXZVRl9GNDNpeHRSRjY2Z2xfdHVVd2FEd0tPZF9ldHl3YWpyaTdlcnNIUzFERjZfOUltNUI0OFVlWlVXODN4alFIODBPT29YdWpxTXRiTmFnZnNzYzQwYi1xM2hSSzR4V0kzcmJKUmlYY1h3UFE1NkhvSGh2TmRiZ3ZuUDN1aFhyTktuUQ?oc=5","date":"2025-07-17","type":"trial","source":"PharmaTimes","summary":"Seaport Therapeutics begins phase 2b trial of GlyphAllo for major depression - PharmaTimes","headline":"Seaport Therapeutics begins phase 2b trial of GlyphAllo for major depression","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE5PRmJCcXBJRGY2bWtqM3ZJV1pFbEFNejBuY1JTbGVYSXZ4bG5zUmVFS0NCR1FGcW1XMG8zQnZrUWJGNGRHeWUwbDN6bERweVZQcS02T3B5b3BoOEd3OHRj?oc=5","date":"2024-12-11","type":"pipeline","source":"Nature","summary":"People - Nature","headline":"People","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxNa3h6b1JGcFdjeFR2QUpBWUN1TkowMUZPbHQtQ29aQ1d5QlFQdjBuUm5tZ3N1cnpNeVVTYmxDOVhxMnNrT0NzRkVGZnFITnNrMmJuRE9IZ1JhanVDMU9paGM4TjhRdUVQUEo5OGFPc0hMd0g3NEtyUFpNQXdzVTh5MDE2QTVFN0NKeWJpV2xQWmUwaFRzSTFNRzVhaEFQbmc?oc=5","date":"2024-10-27","type":"pipeline","source":"MedCity News","summary":"Seaport Therapeutics Secures $225M for New Kind of Depression Drug - MedCity News","headline":"Seaport Therapeutics Secures $225M for New Kind of Depression Drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_wFBVV95cUxPNUZuMlEwZDhRV241NmdCcWtmUzUzSEtRZ1FUOW14UEJYdGJjbmhzLTd5Nldmb3ZLSUZzcU1LdC12b2FXZUFPRDFvU0hhLU9uRndESmZRMmMxaUtoZ2FhRHBUdlNuWkFjRGR2cFQ3LXR1M25MMXotUmExRy1Td194NnJOVk5ZZDJUU2ZySk84eEtaMXBFNmE4cHIwYkFIcE81VTIxaUJtTG93ejVkcWJZTlJaVUNycFV4VEFacDFSRHRvT1ltUy1xM1hoTTZ6a1JDa0toX1Z4N0lVVlE3WlhxNUl5MG9HMmRta1ZQZGZ3aU1NWGF3ZGRKZXFwSW1wcFE?oc=5","date":"2024-10-23","type":"pipeline","source":"Monash University","summary":"Seaport Therapeutics secures US$225 million Series B funding to develop neuropsychiatric medicines using Monash University prodrug technology - Monash University","headline":"Seaport Therapeutics secures US$225 million Series B funding to develop neuropsychiatric medicines using Monash Universi","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxOYTh0MllxQ0pTNmVMblN3a1h3bGN0cDlEQm9KVTU4WXl0TEs1RG12WDloUHNxRDM5TWFZUUNWMDJ2UnROSTRGeTc3RUJMNkVlTjd5dlpPMjMzZ1JETmJYaFhnYTRtZTU3aXdWYU1kQUVVSWlPS0hwYXNBcGZqcG9CZXpTZ0ZWaVRmaDZ2UmFhb09NTUFMR29RLUg5OHBMRHR1WFMzS2s1aw?oc=5","date":"2024-10-21","type":"pipeline","source":"BioPharma Dive","summary":"Brain drug developer Seaport raises another $225M - BioPharma Dive","headline":"Brain drug developer Seaport raises another $225M","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxQOFFRaUtld2NaYVhqVTBYNkkxeDVqT1BScnlVbVRTT0xtRTFFeWdGcHJ6WWh1a0lObnlpcm1Wb2hON3gtZGhfZTRQY1REc1pCdFpBZzRYRXVmMUw0dEZRQjdCZ29wUTZVQUp0UjRUUGllbVNCeGsxeUZJMWV0ZnUtX0pQQTBTWDZXOEhUelJIdGVxQQ?oc=5","date":"2024-10-21","type":"pipeline","source":"The Pharma Letter","summary":"Seaport Therapeutics closes $225 million financing - The Pharma Letter","headline":"Seaport Therapeutics closes $225 million financing","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxPLXhGclc0WUo3N3dsU1FpNXV6OFZNZGw4X3Q0Mld1SzA2bzh6ZVljT2RBRDhIUGFQOWNaMEp1MWF6eUE2d2RWTHFGdzJDSnFjdkoxNE5MSFU5dTdER25vMlFPSEczalRLYWVmbWxackhvQmgxZlRVbnlYc3VXMzN6Q1ltbThLbzNKTW9DZE5fQXBncklfMDVSMTE4X3JESEstei1ydHZpdzY3azFNaWg4ME1jREJJVXQ0?oc=5","date":"2024-10-21","type":"pipeline","source":"Pharmaceutical Technology","summary":"Seaport raises $225m to advance portfolio of neuropsychiatric prodrugs - Pharmaceutical Technology","headline":"Seaport raises $225m to advance portfolio of neuropsychiatric prodrugs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxNYUZTQTZMelN2eGl2ZTV4ZWNxT2ZfRXpkbFp5TnE1aTJmY2djVkY1S3g4MVRhVkhRTlJhbExJZ2tScUEybHRockVPT1owNFFlcHVlQnBLdWtGal9vUUY3c3VvUTBXMUp6WVpoQVhEYnpBNzhyNFRvSzVsZTlLRThTWGtmMkxLNFFWZEFveHN0bXd2QXlsOFRoTlFJVmxlTzQ?oc=5","date":"2024-04-09","type":"pipeline","source":"Genetic Engineering and Biotechnology News","summary":"Seaport Therapeutics Launches with $100M Series A - Genetic Engineering and Biotechnology News","headline":"Seaport Therapeutics Launches with $100M Series A","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}